Biotech entity
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention AI-enabled diagnostics, the most common co-covered peer. At 7, the average consequence score sits above the same-window beat average of 6.
Last mentioned: Feb 19, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention AI-enabled diagnostics, the most common co-covered peer. At 7, the average consequence score sits above the same-window beat average of 6. Source depth averages 2 original sources per story, versus 2.4 across the same-window beat baseline. Medical devices appears in 1 tracked Biotech story from February 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 27 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Medical devices. Shared-story counts are live from our verified record — not editorial picks.
The India AI Impact Summit 2026 in New Delhi is showcasing a paradigm shift in healthcare delivery, focusing on AI-powered diagnostics to bridge the rural-urban divide. Experts emphasize that these technologies are critical to making quality care affordable across the Global South.
Medical devices is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
